Sotera Health Co (SHC)
11.30
-0.12
(-1.01%)
USD |
NASDAQ |
May 17, 16:00
11.30
0.00 (0.00%)
After-Hours: 20:00
Sotera Health Revenue (Quarterly): 248.18M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 248.18M |
| December 31, 2023 | 310.24M |
| September 30, 2023 | 263.18M |
| June 30, 2023 | 255.28M |
| March 31, 2023 | 220.59M |
| December 31, 2022 | 251.59M |
| September 30, 2022 | 248.70M |
| June 30, 2022 | 266.64M |
| March 31, 2022 | 236.75M |
| December 31, 2021 | 241.25M |
| Date | Value |
|---|---|
| September 30, 2021 | 226.16M |
| June 30, 2021 | 251.92M |
| March 31, 2021 | 212.15M |
| December 31, 2020 | 216.84M |
| September 30, 2020 | 200.03M |
| June 30, 2020 | 213.08M |
| March 31, 2020 | 188.20M |
| December 31, 2019 | 193.48M |
| September 30, 2019 | 195.32M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
188.20M
Minimum
Mar 2020
310.24M
Maximum
Dec 2023
233.66M
Average
236.75M
Median
Mar 2022
Revenue (Quarterly) Benchmarks
| Fonar Corp | 25.72M |
| XWELL Inc | 7.403M |
| ProPhase Labs Inc | 3.634M |
| Applied DNA Sciences Inc | 0.9296M |
| Veracyte Inc | 96.84M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 6.323M |
| Total Expenses (Quarterly) | 195.00M |
| EPS Diluted (Quarterly) | 0.02 |
| Enterprise Value | 5.164B |
| Gross Profit Margin (Quarterly) | 51.22% |
| Profit Margin (Quarterly) | 2.55% |
| Earnings Yield | 1.68% |
| Operating Earnings Yield | 9.28% |
| Normalized Earnings Yield | 2.537 |